Decreased MAO-B levels in the vitamin D supplementation group imply attenuated neurotoxic reactive astrocytosis in the AD mouse model and relate to the rebound memory function after the onset of the main symptoms. This evidence concerns the gene MAOB and Alzheimer disease.